Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45

Biocon

BSE: 532523  |  NSE: BIOCON  |  ISIN: INE376G01013  |  Pharmaceuticals
    
 

Have a tip or information to share on Biocon?


Message   Positive opinion   Negative opinion   Query   Grievance   
View by : 
Latest Messages   |   Most Active   |   Top Rated   |   Top Tracked   |   Active Boarders
Go to page:   1    2    3    4    5    6    Next  [  ]    
Sort by:   
Positive Opinions   |   Negative Opinions   |   Queries   |   Grievances   |   ALL
20 Nov 2009 21:58

buy.....

Posted by : sanecouncel.
Price when posted : BSE: Rs 267.90 ( 1.82 % ), NSE: Rs. 268.45 ( 2.11 % )

who are other two players...buccal players!!!!!!!!!!...

19 Nov 2009 11:32

buy.....

Posted by : tara23
Price when posted : BSE: Rs 273.65 ( 1.43 % ), NSE: Rs. 275.20 ( 1.93 % )

thanks for the information....

19 Nov 2009 11:26

buy.....

Posted by : sanecouncel.
Price when posted : BSE: Rs 271.95 ( 0.80 % ), NSE: Rs. 272.70 ( 1.00 % )

100 percent wrong dear, read followong question and answer on
dition(dot)cnn(dot)com/2008/WORLD/asiapcf/11/14/india.mazumdarshaw/index.html
question:Can Biocon`s oral insulin IN-105 replace traditional and painful needle based insulin delivery system for type1 diabetics? Can a diabetic who is taking insulin by needle based delivery system hope for change in near future

Mazumdar-Shaw: Oral Insulin is not just about delivering Insulin in a tablet. It is about delivering Insulin very rapidly to the liver (hepato-delivery) which is the main organ responsible for glycemic control in our body. Injectable Insulin takes approximately 30 minutes to act. Oral Insulin takes approximately 5 minutes to act which mimics how non-diabetics respond to glucose uptake when food is consumed. This will help both Type I and Type II diabetics to manage their diabetes better.

We hope that early intervention with Oral Insulin will help to manage Diabetes especially in Type II diabetics much more effectively than is being done by oral diabetic agents like Metformin, Sulphonyl Ureas and Glitazones which stimulate the pancreas to produce Insulin.

This is unlike oral Insulin which will allow a poorly functioning pancreas to rest and hopefully help to revive Insulin secreting beta cells. Should our Oral Insulin program succeed, this will revolutionize Diabetes therapy in the future.

...

19 Nov 2009 07:11

buy.....

Posted by : chaloo bhai
Price when posted : BSE: Rs 269.80 ( 0.56 % ), NSE: Rs. 270.00 ( 0.73 % )

oral insulin is already 3 years behind schedule. and before it is launched there is a risk that other two international player may launch it in indian market....

18 Nov 2009 23:53

buy.....

Posted by : tara23
Price when posted : BSE: Rs 269.80 ( 0.56 % ), NSE: Rs. 270.00 ( 0.73 % )

yes u may be right....

18 Nov 2009 20:41

buy.....

Posted by : radhika_nandlal
Price when posted : BSE: Rs 269.80 ( 0.56 % ), NSE: Rs. 270.00 ( 0.73 % )

Guest,

Well other oral medicines to treat diabets are nothing but another form of oral insulin only... i dont see why an oral medicine replacing the prick should make a difference to Biocon`s revenues... in fact oral administration is not well absorbed only the serum base is well assimilated, else why would we have insulin shots replacing oral diabetic drugs in the first place??...

18 Nov 2009 17:03

buy.....

Posted by : Guest
Price when posted : BSE: Rs 269.80 ( 0.56 % ), NSE: Rs. 270.00 ( 0.73 % )

nothing is impossible in stock market. watch out for ORAL INSULIN recently in last stage of phase 3 trial, if successful biocon can do wonders,
buy 100-200 take a chance!...

18 Nov 2009 13:04

buy.....

Posted by : kumar.varun
Price when posted : BSE: Rs 271.30 ( 1.12 % ), NSE: Rs. 271.70 ( 1.36 % )

Biocon is a good stock, but your valuation of 20000 is unrealistic.. ...

18 Nov 2009 12:44

buy.....

Posted by : kumar.varun
Price when posted : BSE: Rs 271.45 ( 1.17 % ), NSE: Rs. 271.50 ( 1.29 % )

I know that the stock is good.but ur valuation of 20000 is unrealistic.....

17 Nov 2009 23:44

buy.....

Posted by : shashank1602
Price when posted : BSE: Rs 268.30 ( -1.51 % ), NSE: Rs. 268.05 ( -1.65 % )

I think this is a typo mistake an zero is placed extra that`s my view definately biocon has a huge potential depending upon in 105 molecule...

17 Nov 2009 14:01

buy.....

Posted by : adb
Price when posted : BSE: Rs 266.50 ( -2.17 % ), NSE: Rs. 266.55 ( -2.20 % )

What is the reason for your optimism...

16 Nov 2009 18:40

buy.....

Posted by : Guest
Price when posted : BSE: Rs 272.40 ( 2.85 % ), NSE: Rs. 272.55 ( 2.73 % )

Only stock that is undervalued in this market. Watch out... in 5 years this stock would not be available for less than Rs 20,000!!!...

16 Nov 2009 17:23

buy.....

Posted by : Guest
Price when posted : BSE: Rs 272.40 ( 2.85 % ), NSE: Rs. 272.55 ( 2.73 % )

day dreaming!!!!!...

16 Nov 2009 16:20

buy.....

Posted by : mitalsanghvi
Price when posted : BSE: Rs 272.40 ( 2.85 % ), NSE: Rs. 272.55 ( 2.73 % )

sure shot. target very soon...

16 Nov 2009 14:25

Heading

Posted by : Guest
Price when posted : BSE: Rs 273.00 ( 3.08 % ), NSE: Rs. 273.05 ( 2.92 % )

i think co is sleeping management is sleeping
i should direcetly talk to for this wrong share price
instead of 10000+
...